Literature DB >> 31844383

Relationship Between Substance Use and the Onset of Spinal Cord Injuries: A Medical Chart Review.

Lori Ann Eldridge1,2, Jennifer A Piatt3, Jon Agley1,2, Steven Gerke4,5.   

Abstract

Background: Opioid misuse is a leading health care concern within the United States. In many cases, opioid misuse and opioid use disorder are associated with pain, a secondary health condition affecting individuals with spinal cord injury (SCI). Further, substance use is a known risk factor for SCI, resulting in the potential for a substance-related risk trajectory running from pre- to post-SCI. However, little research has examined substance use prior to SCI since the opioid epidemic began, and so the relative risk of opioids to patients with SCI is unclear. Objective: To determine whether individuals with SCI tested positive for substance use at the time of injury and identify the primary substances used at the time of injury.
Methods: This study retrospectively reviewed all medical charts of individuals ages 18 and older who had sustained an SCI during an identified 18-month period and received medical care at a selected level 1 trauma center in the Midwest.
Results: Data revealed an 80% combined positive toxicology and/or self-report of substance use immediately prior to the onset of the SCI. Twenty-five percent of males were positive for more than one substance at time of injury. Substances used prior to injury, listed most to least prevalent, were opioids (37.5%), alcohol (25%), marijuana (25%), methamphetamines (12.5%), benzodiazepines (12.5%), followed by cocaine (6.25%) and synthetic cathinone (6.25%).
Conclusion: Although opioids were the most common substance used prior to SCI, none of the individuals positive for opioids at the time of injury were identified by the reviewing medical professional as having pain as a secondary health condition either prior to or after injury. However, pain is commonly listed as the primary health concern among individuals living with SCI, and the possibility of opioid use prior to injury likely warrants pain management planning that includes careful pharmacological and nonpharmacological interventions.
© 2019 Thomas Land Publishers, Inc.

Entities:  

Keywords:  pain; spinal cord injury; substance use

Mesh:

Year:  2019        PMID: 31844383      PMCID: PMC6907031          DOI: 10.1310/sci2504-316

Source DB:  PubMed          Journal:  Top Spinal Cord Inj Rehabil        ISSN: 1082-0744


  19 in total

Review 1.  Major increases in opioid analgesic abuse in the United States: concerns and strategies.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2005-07-14       Impact factor: 4.492

2.  Health Conditions: Effect on Function, Health-Related Quality of Life, and Life Satisfaction After Traumatic Spinal Cord Injury. A Prospective Observational Registry Cohort Study.

Authors:  Carly S Rivers; Nader Fallah; Vanessa K Noonan; David G Whitehurst; Carolyn E Schwartz; Joel A Finkelstein; B Catharine Craven; Karen Ethans; Colleen O'Connell; B Catherine Truchon; Chester Ho; A Gary Linassi; Christine Short; Eve Tsai; Brian Drew; Henry Ahn; Marcel F Dvorak; Jérôme Paquet; Michael G Fehlings; Luc Noreau
Journal:  Arch Phys Med Rehabil       Date:  2017-07-19       Impact factor: 3.966

Review 3.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Authors:  Andrew Kolodny; David T Courtwright; Catherine S Hwang; Peter Kreiner; John L Eadie; Thomas W Clark; G Caleb Alexander
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

Review 4.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

5.  Pre-injury substance abuse among persons with brain injury and persons with spinal cord injury.

Authors:  S A Kolakowsky-Hayner; E V Gourley; J S Kreutzer; J H Marwitz; D X Cifu; W O Mckinley
Journal:  Brain Inj       Date:  1999-08       Impact factor: 2.311

6.  Preinjury alcohol and drug use among persons with spinal cord injury: implications for rehabilitation.

Authors:  Michael W Stroud; Charles H Bombardier; Joshua R Dyer; Carl T Rimmele; Peter C Esselman
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

7.  Patterns of alcohol and substance use and abuse in persons with spinal cord injury: risk factors and correlates.

Authors:  Denise G Tate; Martin B Forchheimer; James S Krause; Michelle A Meade; Charles H Bombardier
Journal:  Arch Phys Med Rehabil       Date:  2004-11       Impact factor: 3.966

8.  Post-injury substance abuse among persons with brain injury and persons with spinal cord injury.

Authors:  Stephanie A Kolakowsky-Hayner; Eugene V Gourley; Jeffrey S Kreutzer; Jennifer H Marwitz; Michelle A Meade; David X Cifu
Journal:  Brain Inj       Date:  2002-07       Impact factor: 2.311

9.  Problematic secondary health conditions among adults with spinal cord injury and its impact on social participation and daily life.

Authors:  Jennifer A Piatt; Shinichi Nagata; Melissa Zahl; Jing Li; Jeffrey P Rosenbluth
Journal:  J Spinal Cord Med       Date:  2015-12-15       Impact factor: 1.985

10.  Alcohol use associated with cervical spinal cord injury.

Authors:  Anne Garrison; Kara Clifford; Stacy F Gleason; Carlos G Tun; Robert Brown; Eric Garshick
Journal:  J Spinal Cord Med       Date:  2004       Impact factor: 1.985

View more
  2 in total

1.  Blood Alcohol Concentration Is Associated With Improved AIS Motor Score After Spinal Cord Injury.

Authors:  Josephine Volovetz; Mary Joan Roach; Argyrios Stampas; Gregory Nemunaitis; Michael L Kelly
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021-01-20

2.  The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review.

Authors:  Kylie J Nabata; Emmanuel K Tse; Tom E Nightingale; Amanda H X Lee; Janice J Eng; Matthew Querée; Matthias Walter; Andrei V Krassioukov
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.